These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10769748)

  • 1. Q vectors, bicistronic retroviral vectors for gene transfer.
    Julius MA; Yan Q; Zheng Z; Kitajewski J
    Biotechniques; 2000 Apr; 28(4):702-8. PubMed ID: 10769748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site.
    Ramesh N; Kim ST; Wei MQ; Khalighi M; Osborne WR
    Nucleic Acids Res; 1996 Jul; 24(14):2697-700. PubMed ID: 8758998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicistronic and two-gene retroviral vectors for using MDR1 as a selectable marker and a therapeutic gene.
    Metz MZ; Matsumoto L; Winters KA; Doroshow JH; Kane SE
    Virology; 1996 Mar; 217(1):230-41. PubMed ID: 8599208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
    Chen L; Perlick H; Morgan RA
    Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient gene transfer and expression in primary B lymphocytes.
    Overell RW; Weisser KE; Hess BW; Ziegler SF; Pleiman CM; Maliszewski C; Grabstein KH
    J Immunol Methods; 1991 Jul; 141(1):53-62. PubMed ID: 1865123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting retroviral vector function and structural integrity.
    McLachlin JR; Mittereder N; Daucher MB; Kadan M; Eglitis MA
    Virology; 1993 Jul; 195(1):1-5. PubMed ID: 8391178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved retroviral vectors for gene transfer and expression.
    Miller AD; Rosman GJ
    Biotechniques; 1989 Oct; 7(9):980-2, 984-6, 989-90. PubMed ID: 2631796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transient three-plasmid expression system for the production of high titer retroviral vectors.
    Soneoka Y; Cannon PM; Ramsdale EE; Griffiths JC; Romano G; Kingsman SM; Kingsman AJ
    Nucleic Acids Res; 1995 Feb; 23(4):628-33. PubMed ID: 7899083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
    Weber EL; Cannon PM
    Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
    Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M
    J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved gene expression by a U3-based retroviral vector.
    Chen BF; Hsieh CL; Chen DS; Hwang LH
    Biochem Biophys Res Commun; 1992 Apr; 184(1):330-7. PubMed ID: 1567440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transduction into murine primitive hematopoietic cells with 2-gene retroviral vectors using a Transwell coculture system.
    Asami N; Germeraad WT; Fujimoto S; Nagai S; Izumi T; Katsura Y
    Eur J Haematol; 1996 Oct; 57(4):278-85. PubMed ID: 8982290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral vectors encoding a reverse transcription-activated transgene efficiently limit expression of the gene to target cells.
    Burke JD; Morris JC
    Mol Ther; 2007 Mar; 15(3):552-9. PubMed ID: 17191073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
    Addison CL; Hitt M; Kunsken D; Graham FL
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
    Kim T; Leibfried-Rutledge ML; First NL
    Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette.
    Hofmann A; Nolan GP; Blau HM
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5185-90. PubMed ID: 8643550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.